omeprazole and 6 beta-hydroxycortisol

omeprazole has been researched along with 6 beta-hydroxycortisol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Fuchs, W; Klotz, U; Sennewald, R1
Brösicke, H; Heinemeyer, G; Roots, I; Rost, KL1
Mansmann, U; Roots, I; Rost, KL1
Echizen, H; Nachi, S; Ohnishi, A; Ushiama, H1
Akizuki, S; Echizen, H; Mochizuki, J; Murakami, S; Ohnishi, A; Takagi, I1

Trials

4 trial(s) available for omeprazole and 6 beta-hydroxycortisol

ArticleYear
Lansoprazole does not affect the bioavailability of oral contraceptives.
    British journal of clinical pharmacology, 1994, Volume: 38, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Biological Availability; Chromatography, High Pressure Liquid; Contraceptives, Oral; Cross-Over Studies; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glucaric Acid; Humans; Hydrocortisone; Lansoprazole; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Omeprazole; Progesterone; Proton Pump Inhibitors; Sex Hormone-Binding Globulin; Therapeutic Equivalency

1994
Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment.
    International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Estradiol Congeners; Ethinyl Estradiol; Female; Glucaric Acid; Humans; Hydrocortisone; Lansoprazole; Levonorgestrel; Omeprazole; Placebos; Progesterone Congeners

1997
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Clinical pharmacology and therapeutics, 2002, Volume: 72, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrocortisone; Lansoprazole; Liver Function Tests; Male; Middle Aged; Omeprazole; Oxidoreductases, N-Demethylating; Penicillins; Protein Synthesis Inhibitors

2002
In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease.
    Journal of clinical pharmacology, 2005, Volume: 45, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Enzyme Inhibitors; Female; Genotype; Hepatitis C, Chronic; Humans; Hydrocortisone; Liver Cirrhosis; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic

2005

Other Studies

2 other study(ies) available for omeprazole and 6 beta-hydroxycortisol

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Specific and dose-dependent enzyme induction by omeprazole in human beings.
    Hepatology (Baltimore, Md.), 1994, Volume: 20, Issue:5

    Topics: Absorption; Adolescent; Adult; Aged; Aged, 80 and over; Caffeine; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Induction; Female; gamma-Glutamyltransferase; Glutarates; Half-Life; Humans; Hydrocortisone; Male; Mephenytoin; Methylation; Middle Aged; Omeprazole; Oxidoreductases

1994